CN102727698B - Wound surface nursing powder for treating bedsore - Google Patents
Wound surface nursing powder for treating bedsore Download PDFInfo
- Publication number
- CN102727698B CN102727698B CN201210242145.3A CN201210242145A CN102727698B CN 102727698 B CN102727698 B CN 102727698B CN 201210242145 A CN201210242145 A CN 201210242145A CN 102727698 B CN102727698 B CN 102727698B
- Authority
- CN
- China
- Prior art keywords
- parts
- wound surface
- powder
- bedsore
- surface nursing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a wound surface nursing powder for treating bedsore, which aims at resolving a nursing problem of the bedsore. The wound surface nursing powder is characterized by being obtained by processing various traditional Chinese medicines, the raw material ingredients and weight proportions are as follows: 6-10 parts of dragon blood, 8-15 parts of elephant hide, 8-15 parts of frankincense, 6-10 parts of myrrh, 6-10 parts of lycopodium, 8-15 parts of beach morningglory herb, 6-10 parts of acacia catechu, 30-45 parts of radix angelicae and 30-40 parts of rhizoma atractylodis. Clinical experiments prove that the wound surface nursing powder has good curative effect on treating the bedsore with high safety and is worthy of clinical application and promotion.
Description
Technical field
The present invention relates to nursing care of decubitus ulcer field, be specifically related to a kind of wound surface nursing powder for the treatment of decubital ulcer.
Background technology
Decubital ulcer is due to patient's long-term bed and nurses the improper rotten downright bad ulcer region producing such as de-of body surface bulge region pressurized, local Hypoxia and ischemia, blood vessel embolism, tissue necrosis that causes.Primary disease is more common in the patient of the long-term beds such as stupor, hemiplegia, paralysis, is also found in the patients such as dressing compressing tension, the limbs stump of wearing artificial limb, various hands postoperative position limitation of activity.Up to the present, for the care method of decubital ulcer mainly: wound surface is shallow, little, and pus oozes out few person, first uses povidone iodine routine disinfection, with cotton swab, dip in normal saline and add gentamycin 80,000 U and from inside to outside repeatedly clean afterwards, fully expose 1 time/d; Wound surface is dark, large, and pus oozes out more person, slough blackout and frowziness person, first with 3% hydrogen peroxide liquid, thoroughly clean, prune slough, until expose fresh granulation tissue, then with physiological saline solution, add gentamycin 80,000 U and rinse wound surface, with aseptic dressing, cover 2 times/d.The weak point of the method is: 1. take partial sterilization as main, when middle and late stage granulation starts to form, povidone iodine etc. have produced stimulation to granulation, easily cause granulation dysplasia, and new meat is not raw; 2. rinse and add the therapeutic scheme that dressing covers, transudate is easy to and dressing adhesion, produces new wound while causing change dressings next time.
Summary of the invention
Technical assignment of the present invention is for above the deficiencies in the prior art, and the wound surface nursing powder of the sure treatment decubital ulcer of a kind of curative effect is provided.
The technical scheme that the present invention solves its technical problem is: a kind of wound surface nursing powder for the treatment of decubital ulcer, it is characterized in that being processed by plurality of Chinese, its composition of raw materials and weight proportion are: 6 ~ 10 parts of Sanguis Draxonis, 8 ~ 15 parts of Corium elephatiss, 8 ~ 15 parts of Olibanums, 6 ~ 10 parts of Myrrhas, 6 ~ 10 parts of Spora Lycopodiis, 8 ~ 15 parts of Herba Ipomoeae Pes-Capraes, 6 ~ 10 parts, catechu, 30 ~ 45 parts of the Radixs Angelicae Dahuricae, 30 ~ 40 parts of Rhizoma Atractylodis.
Its optimum weight proportioning is: 8 parts of Sanguis Draxonis, 10 parts of Corium elephatiss, 10 parts of Olibanums, 8 parts of Myrrhas, 8 parts of Spora Lycopodiis, 10 parts of Herba Ipomoeae Pes-Capraes, 8 parts, catechu, 40 parts of the Radixs Angelicae Dahuricae, 35 parts of Rhizoma Atractylodis.
Wherein said: Sanguis Draxonis, the resin oozing out for babassu Sanguis Draxonis Daemonorops draco Blume. fruit is through being processed into.Nature and flavor are sweet, salty, flat.GUIXIN, Liver Channel.Merit can removing blood stasis and relieving pain, hemostasia and promoting granulation.
Corium elephatis is the skin of Elephantidae animal elephant Elephas maximus L..Nature and flavor are sweet, salty, temperature.Merit can granulation promoting, sore.
Olibanum, the oleo-gum-resin of oozing out for trunk skin zone wounds such as Burseraceae Boswellia carterii platymiscium Boswellia carterii Boswellia carterii Birdw., medicine glue XIANGSHU B. bhawdajiana Birdw. and wild Boswellia carterii B. neglecta M. Moore.Nature and flavor are pungent, bitter, temperature.GUIXIN, liver, spleen channel.Merit can regulating qi and activating blood, and analgesic therapy, chases after poison.
Myrrha, for Burseraceae bdellium plant myrrh Commiphora myrrha Engl. and belong to the oleo-gum-resin that the trunk skin zone of his kind of plant oozes out together.Nature and flavor are bitter, flat.Return Liver Channel.The merit blood blood stasis removing that can fall apart, subduing swelling and relieving pain.
Spora Lycopodii is lycopsid Lycopodium clavatum copodium japonicum Thunb., Herba Lycopodii Obscuri Lycopodium clavatum Lycopodium centro-chinense Ching, Spora Lycopodii Palhinhaea cernua(L.) spore of Franco et Vasc. and single fringe Lycopodium clavatum Lycopodium cernuum L..Nature and flavor are bitter; Temperature.Return liver; Spleen channel.Merit can removing dampness; Sore; Cough-relieving.
Herba Ipomoeae Pes-Capraes, the herb of Convolvulaceae morning glory two leaf Radix Ipomoeae Ipomoea pescarpae (L.) Sweet.Pungent, the micro-hardship of nature and flavor, wet.Merit can expelling wind and removing dampness, the detumescence of drawing out pus by applying a plaster to the affected part.
Catechu, is pulse family albizzia plant catechu tree Acacia catechu(L. f.) the peeling branch of Willd., dry dry soft extracts.Nature and flavor are bitter, puckery, are slightly cold.Return lung meridian.Merit can removing dampness promoting tissue regeneration and ulcer healing.
Plant Radix Angelicae Dahuricae Angelica dahurica (Fisch.ex Hoffm.) the Benth. et Hook.f. of Radix Angelicae Dahuricae ，Wei umbellate form section or Radix angelicae dahuricae Angelica dahurica(Fisch.ex Hoffm.) Benth.et Hook.f. var.formosana(Boiss.) dry root of Shan et Yuan.Nature and flavor are pungent, temperature.Return stomach, large intestine, lung meridian.Can fall apart wind dehumidifying of merit, understand things pain-stopping, detumescence and apocenosis.
Rhizoma Atractylodis are the dry rhizome of feverfew Atractylodes lancea (Thunb.) DC. Atractylodes lancea (Thunb.) DC. or Atractylis chinensis Atractylodes chinensis (DC.) Koidz..Nature and flavor are pungent, bitter, temperature.Return spleen, stomach, Liver Channel.Merit can be drying damp and strengthening spleen, expelling wind and cold, improving eyesight.
Composition principle: the traditional Chinese medical science thinks that decubital ulcer is many because of deficient qi and blood, qi depression to blood stasis causes, prolonged illness is liied in bed in vain, pressurized position stagnation of QI-blood, blood vessels are obstructed, and meridians intercept, and deficiency of both QI and blood, invades in malicious heresy, and the mistake of muscle muscles and bones is supported the rotten skin ulcer that becomes of bursting, and touching difficulty heals.Treat at present multiplex cold and cool medicine removing the necrotic tissue and promoting granulation, but in the process for the treatment of patients with decubitus, wound surface granulation well being grown, is the key of decubital ulcer healing.Inventor, in clinical empirical summary discovery for many years, promotes local vascular newborn, corrects local organization ischemic state, improves blood circulation, for granulation tissue growth provides nutrition, is to be key.Meanwhile, should note effectively reducing and oozing out, prevent loss of proteins, can contribute to like this improvement of local microenvironment, promote healing.Therefore we get Sanguis Draxonis hemostasis by removing blood stasis granulation promoting, Olibanum regulating qi and activating blood, the loose blood blood stasis removing detumescence of Myrrha; Herba Ipomoeae Pes-Capraes, Rhizoma Atractylodis expelling wind and removing dampness; Corium elephatis, Spora Lycopodii, catechu removing dampness expelling pus and promoting granulation; The loose wind dehumidifying of the Radix Angelicae Dahuricae, detumescence and apocenosis.All medicines share above, play altogether the effect of invigorate blood circulation dehumidifying, expelling pus and promoting granulation, have promoted local blood circulation and angiogenesis, and minimizing is oozed out, and effectively prevents loss of proteins, thereby alleviate decubitus symptom, and have accelerated the healing of decubital ulcer.
The specific embodiment
Below in conjunction with practical situation, the specific embodiment of the present invention is elaborated.
Embodiment 1, crude drug weight proportion: Sanguis Draxonis 6g, Corium elephatis 8g, Olibanum 8g, Myrrha 6g, Spora Lycopodii 6g, Herba Ipomoeae Pes-Capraes 8g, catechu 6g, Radix Angelicae Dahuricae 30g, Rhizoma Atractylodis 30g.
Embodiment 2, crude drug weight proportion: Sanguis Draxonis 10g, Corium elephatis 15g, Olibanum 15g, Myrrha 10g, Spora Lycopodii 10g, Herba Ipomoeae Pes-Capraes 15g, catechu 10g, Radix Angelicae Dahuricae 45g, Rhizoma Atractylodis 40g.
Embodiment 3, crude drug weight proportion: Sanguis Draxonis 8g, Corium elephatis 10g, Olibanum 10g, Myrrha 8g, Spora Lycopodii 8g, Herba Ipomoeae Pes-Capraes 10g, catechu 8g, Radix Angelicae Dahuricae 40g, Rhizoma Atractylodis 35g.
During use, by Chinese medicine Resina draconis of the present invention, Corium elephatis, Olibanum, Myrrha, Spora Lycopodii, Herba Ipomoeae Pes-Capraes, catechu, Rhizoma Atractylodis and the Radix Angelicae Dahuricae, grind to the powder altogether, autoclave sterilization external application.
Effective combination of above-mentioned wound surface nursing powder, coordinates mutually, can effectively reach the object for the treatment of decubital ulcer, and side effect is less.The above results is that clinical data fully proves, interrelated data is as follows, and wherein studying the use of wound surface nursing powder is the crude drug weight proportion in embodiment 3.
1 object and method.
1.1 objects: the 71 examples decubital ulcer patients that are in hospital, male's 42 examples wherein, women's 29 examples; Age reckling 28 years old, the maximum 82 years old; The course of disease is the shortest 1 week, the longest 40 days; Minimum 2cm * the 2cm of area, maximum 10cm * 10cm.
1.2 method.
1.2.1 grouping: divide at random two groups, treatment group 41 examples, matched group 30 examples, clinical data there was no significant difference (P>0.05) between two groups.
1.2.2 Therapeutic Method: matched group: wound surface is shallow, little, pus oozes out few person, first uses povidone iodine routine disinfection, with cotton swab, dips in normal saline and adds gentamycin 80,000 U and from inside to outside repeatedly clean afterwards, fully exposes 1 time/d; Wound surface is dark, large, and pus oozes out more person, slough blackout and frowziness person, first with 3% hydrogen peroxide liquid, thoroughly clean, prune slough, until expose fresh granulation tissue, then with physiological saline solution, add gentamycin 80,000 U and rinse wound surface, with aseptic dressing, cover 2 times/d.The incrustation of skin ulcer face, can 1 time/d after fresh granulation grows.Treatment group data scheme is on matched group basis, to add the embodiment of the present invention 3 gained Chinese medicines to grind to the powder altogether again, and autoclave sterilization external application, every day 1 time, 7 days is 1 course for the treatment of, continuous 4 courses for the treatment of.
1.2.3 observation index: observe and record whether two groups of new meat of wounds grow, whether new meat tissue cover with, whether wound surface forms a scab, and whether purulent secretion reduces, and whether the swollen gesture of surrounding fades.Observe local skin and whether have anaphylaxis.
1.2.4 curative effect determinate standard: with reference to the < < traditional Chinese medical science disease Standardization of diagnosis and curative effect > > of State Administration of Traditional Chinese Medicine's issue in 1994, recovery from illness: medication 2 to 3 weeks, new meat grows, new meat tissue covers with, wound surface incrustation Quan More; Effective: purulent secretion reduces, the swollen gesture of surrounding fades; Invalid: symptom, sign changes little.
1.2.5 statistical analysis: carry out statistical analysis with SPSS 13.0, P< 0.05 indicates significant.
2 results.
The curative effect comparison of 2.1 liang of group cases: see the following form, cure rate and total effective rate treatment group are obviously better than matched group (P<0.05).
2.2 untoward reaction situations: two groups all without obvious adverse reaction case.
3. conclusion.
The demonstration of this result of study, the present invention treats decubital ulcer determined curative effect, is worthy of promotion and application.
Claims (2)
1. a wound surface for the treatment of decubital ulcer is nursed powder, it is characterized in that being processed by plurality of Chinese, its crude drug forms and weight proportion is: 6 ~ 10 parts of Sanguis Draxonis, 8 ~ 15 parts of Corium elephatiss, 8 ~ 15 parts of Olibanums, 6 ~ 10 parts of Myrrhas, 6 ~ 10 parts of Spora Lycopodiis, 8 ~ 15 parts of Herba Ipomoeae Pes-Capraes, 6 ~ 10 parts, catechu, 30 ~ 45 parts of the Radixs Angelicae Dahuricae, 30 ~ 40 parts of Rhizoma Atractylodis.
2. a kind of wound surface nursing powder for the treatment of decubital ulcer according to claim 1, is characterized in that its weight proportion is: 8 parts of Sanguis Draxonis, 10 parts of Corium elephatiss, 10 parts of Olibanums, 8 parts of Myrrhas, 8 parts of Spora Lycopodiis, 10 parts of Herba Ipomoeae Pes-Capraes, 8 parts, catechu, 40 parts of the Radixs Angelicae Dahuricae, 35 parts of Rhizoma Atractylodis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210242145.3A CN102727698B (en) | 2012-07-13 | 2012-07-13 | Wound surface nursing powder for treating bedsore |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210242145.3A CN102727698B (en) | 2012-07-13 | 2012-07-13 | Wound surface nursing powder for treating bedsore |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102727698A CN102727698A (en) | 2012-10-17 |
| CN102727698B true CN102727698B (en) | 2014-03-12 |
Family
ID=46984462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210242145.3A Active CN102727698B (en) | 2012-07-13 | 2012-07-13 | Wound surface nursing powder for treating bedsore |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102727698B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103566088B (en) * | 2013-10-31 | 2016-01-06 | 刘增慧 | A kind of clinical care is used for the treatment of the preparation method of the medicament of decubital ulcer |
| CN104352568A (en) * | 2014-12-11 | 2015-02-18 | 谭清平 | Traditional Chinese medicine for treating bedsore and preparation method thereof |
| CN109009789A (en) * | 2018-06-01 | 2018-12-18 | 南京梵康医疗科技有限公司 | A kind of Medical nursing pad and its processing technology of pre- counteracting bedsores |
-
2012
- 2012-07-13 CN CN201210242145.3A patent/CN102727698B/en active Active
Non-Patent Citations (2)
| Title |
|---|
| 《生肌愈创膏治疗褥疮临床观察》;于淑花;《中国中医急症》;20030630;第12卷(第3期);225-226 * |
| 于淑花.《生肌愈创膏治疗褥疮临床观察》.《中国中医急症》.2003,第12卷(第3期),225-226. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102727698A (en) | 2012-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101703603B (en) | External-use ointment for treating empyrosis and preparation method thereof | |
| CN101766773B (en) | Chinese medicine prescription for treating talagia | |
| CN102755528A (en) | External Chinese medicine for treating bedsore | |
| CN103230493B (en) | Traditional Chinese medicine composition for treating unhealed wound | |
| CN102125634A (en) | Chinese medicinal composition for treating bedsore | |
| CN100434109C (en) | Medicine ointment for treating burns and scalds and its prepn | |
| CN101011487B (en) | Externally used Chinese patent drug for treating burn and scald and its preparation | |
| CN101919927B (en) | Spray for promoting scald healing | |
| CN103893557A (en) | Traditional Chinese medicine preparation for treating bedsore | |
| CN102727698B (en) | Wound surface nursing powder for treating bedsore | |
| ES2785030T3 (en) | External traditional Chinese medicinal preparation to reduce inflammation, relieve pain and promote rapid healing, and method of preparation for the same | |
| CN112618646A (en) | Traditional Chinese medicine composition and traditional Chinese medicine oil for treating burns and preparation method thereof | |
| CN109602854A (en) | A kind of ointment and preparation method thereof for treating burn and scald | |
| CN105250712B (en) | A kind of Chinese medicine composition for treating bedsore | |
| CN106266140A (en) | A kind of liniment treating acrodermatitis continua and preparation method thereof | |
| CN102284006B (en) | Externally-used paste for treating bedsore and burn-scald wounds | |
| CN105770347A (en) | Pure traditional Chinese medicinal oil for burns, scalds, wounds and ulcers and preparation method of pure traditional Chinese medicinal oil | |
| CN111991471A (en) | A topical Chinese medicinal preparation for treating knife wound, burn and scald, and its preparation method | |
| CN104983936A (en) | Traditional Chinese medicine ointment for treating third-stage bedsore in clinical nursing | |
| CN104800280A (en) | Diabetes hand and foot wound heeling traditional Chinese medicine ointment and preparing method | |
| CN109646512A (en) | A kind of external medicine composition for promoting chronic wound to heal | |
| CN104083421A (en) | Traditional Chinese medicine ointment for treating bedsore and preparation method thereof | |
| CN108653588A (en) | A kind of externally applied Chinese medicine for treating orthopaedic disease | |
| CN102526317B (en) | Chinese medicine applying agent for treating bedsore | |
| CN105832909A (en) | Traditional Chinese medicine preparation for treating necrotic ulcer of skin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20151207 Address after: 225500 No. 1 Su Zhong Road, Jiangyan District, Jiangsu, Taizhou Patentee after: JIANGSU SUZHONG PHARMACEUTICAL GROUP Co.,Ltd. Address before: 276826 Rizhao People's Hospital, 126 Tai'an Road, Shandong, Rizhao City, China Patentee before: Yin Defen |
|
| CP01 | Change in the name or title of a patent holder | ||
| CP01 | Change in the name or title of a patent holder |
Address after: No.1 Suzhong Road, Jiangyan District, Taizhou City, Jiangsu Province 225500 Patentee after: Suzhong Pharmaceutical Group Co.,Ltd. Address before: No.1 Suzhong Road, Jiangyan District, Taizhou City, Jiangsu Province 225500 Patentee before: JIANGSU SUZHONG PHARMACEUTICAL GROUP Co.,Ltd. |